Breast Cancer: Life-Changing Advancements and What's Next?

January 2024 marks two decades since the Oncotype DX Breast Recurrence Score^® test transformed breast cancer treatment. Meet the very first patient who bravely embraced the Oncotype DX^® test after it became available. Discover how it helped her—and over 1 million others—confidently forgo chemotherapy and make more informed treatment decisions.